Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Gel for Post-Bleaching Tooth Sensitivity
NCT06180707Phase 3Not yet recruiting
- Sponsor
- Universidade Federal do Pará
- Start
- Jan 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in dentin hypersensitivity (DH), sponsored by Universidade Federal do Pará. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06180707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06180707.